The Role of Mast Cells in Atherosclerosis

International Archives of Allergy and Immunology

Volumn 114, Issue 1, 1997, Pages 10-14

  Metzler, Bernhard ^a,b   Xu, Qingbo ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Atherosclerosis; Cytokines; Inflammation; LDL; Mast cell

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; LIPID; LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CELL PROLIFERATION; CHRONIC INFLAMMATION; FOAM CELL; HUMAN; LIPID STORAGE; MACROPHAGE; MAST CELL; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SHORT SURVEY; SMOOTH MUSCLE; T LYMPHOCYTE;

EID: 0030876898     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237636     Document Type: Article

References (33)

1. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s, Nature 1993;362: 801-809.
2. Stary HC: Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults, Arteriosclerosis 1989;9: 19-32.
3. Kovanen PT: Role of mast cells in atherosclerosis, C'hcm Immunol 1995;62:132-170.
4. Steinberg DS, Parthasarathy S, Carew TE, Khoo D, Witztum Jl.: Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity, N Engl J Med 1989; 320:915-924.
5. Wick G, Schett G, Amberger A, Klcindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 1995; 16: 27-33.
6. Libby P, Hansson GK: Involvement of the immune system in human athcrogenesis; Current knowledge and unanswered questions, Lab Invest 1991:64:5-15.
7. Hansson GK, Holm J, Jonasson L: Detection of activated T lymphocytes in the human atherosclerotic plaque, Am J Pathol 1989; 135:169-175.
8. Jonasson L, Holm J, Skalli O, Bondjcrs G, Hansson GK: Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque, Arteriosclerosis 1986:6:131-138.
9. Xu Q, Klcindienst R, Waitz W, Dietrich H, Wick G: Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65, J Clin Invest 1993:91:2693-2702.
10. Stemmc S, Holm J, Hasson GK: T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the intcgin VLA-I, Arterioscler Thromb 1992:12:206-211.
11. O'Brien RL, Happ MP, Dallas A, Palmer E, Ku-bo R, Born Wk: Stimulation of a major subset of lymphocytes expressing T cell receptor gamma/delta by an antigen derived from mycobacterium tuberculosis, Cell 1989;57:668-674.
12. Klcindienst R, Xu Q, Willeit J, Waldcnberger F, Weimann S, Wick G: Immunology of atherosclerosis: Demonstration of heat shock protein 60 expression and T lymphocytes bearing «/ J and y/0 receptors in human atherosclerotic lesions, Am J Pathol 1993:152:1927-1937.
13. Vlaicu R, Niculescu F, Rus HG, Cristea A: Im-munohistochemical localization of the terminal C5-b-9 complement complex in human aortic fibrous plaque, Atherosclerosis 1985:57:163-169.
14. Seifert PS, Hansson GK: Complement receptors and regulatory proteins in human atherosclerotic lesions, Arteriosclerosis 1989;9:802-814.
15. Witztum JL: The oxidation hypothesis of atherosclerosis, Lancet 1994:344:793-795.
16. Xu Q, Wick G: The role of heat shock proteins in protection and pathophysiology of the arterial wall, Mol Med Today 1996:2:372-379.
17. Schwartz LB, Austen KF: Structure and function of the chemical mediators of mast cells; in Ishizaka K (cd): Mast Cell Activation and Mediator Release, Prog Allergy, Basel, Karger 1984; vol 34, pp 271-321.
18. Katz HR, Austen KF, Catcrson B, Stevens RL: Secretory granules of heparin-containing rat serosal mast cells also possess highly sulfate chondroitin sulfate proteoglycans, J Biol Chem 1986;261:13393-13396.
19. Lindstedt KA, Kokkonen JO, Kovanen PT: Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoprotein by macrophages via scavenger receptor-mediated phagocytosis, J Lipid Res 1992;33:65-75.
20. Galli SJ: New concepts about the mast cell, N Engl J Med 1993:328:257-265.
21. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acctylatcd low density lipoprotein, producing massive cholesterol deposition, Proc Natl Acad Sci USA 1979:76:333-337.
22. Kokkonen JO, Kovanen PT: Low density lipoprotein degradation by mast cells: Demonstration of extracellular proteolysis caused by mast cell granules, J Biol Chem 1985:260:14756-14763.
23. Kokkonen JO, Vartiainen M, Kovanen PT: Low density lipoprotein degradation by secretory granules of rat serosal mast cells: Sequential degradation of apolipoprotein B by granule chymase and charboxypcptidase A, J Biol Chem 1986;269:2023-2031.
24. Bierman EL, Oram J, Mendez A: HDL receptor-mediated cholesterol efflux from cells and its regulation, Adv Exp Med Biol 1991;285:81-83.
25. Forman MB, Oates JA, Robertson D: Increased adventitial mast cells in a patient with coronary spasm, N Engl J Med 1985:313:1138-1141.
26. Kaariinen M, Pcnttila A, Kovanen PT: Mast cells of two types differing in neutral protease composition in the human aortic intima: Demonstration of tryptasc- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and in the shoulder region of atheromas, Arterioscler Thromb 1994; 14:966-972.
27. Cornhill JF, Ilcrderick EE, Stary HC: Topography of human aortic sudanophilic lesions, Monogr Atherosclerosis 1990; 15:13-19.
28. lnoue Y, King TE Jr, Tinkle SS, Dockstader K, Newman LS: Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders, Am J Pathol 1996:149:2037-2054.
29. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, Hoxie JA, Schcchter N, Woolkalis M, Brass LF: Interactions of mast cell tryptase with thrombin receptors and PAR-2, J Biol Chem 1997;272:4043-4049.
30. Takagishi T, Sasaguri Y, Nakano R, Arima N, Tanimoto A, Fukui H, Morimatsu M: Expression of the histamine H1 receptor gene in relation to athcrogenesis, Am J Pathol 1995:146: 981-988.
31. Mueller IIW, Haught CA, McNatt JM, Cui K, Gaskell SJ, Johnston DA, Willerson JT: Measurement of platelet-activating factor in a canine model of coronary thrombosis and in end-artercctomy samples from patients with advanced coronary disease, Circ Res 1995:77:54-63.
32. Wizc J, Wojtecka-Lukaski E, Malinski S: Collagen derived peptides release mast cell histamine, Agents Actions 1986;18:262-265.
33. Atkins FM, Friedman MM, Subba Rao PV, Mcdcalfe DD: Interactions between mast cells, fibroblasts and connective tissue components, Int Arch Allergy Appl Immunol 1985:7:96-102.